Web Results

In RE: Incretin Mimetics Products Liability Litigation (MDL No. 2452)


Aug 26, 2013 ... Amylin Pharmaceuticals, Inc., et al., C.A. No.3:12-02566 ... Amylin Pharmaceuticals, LLC, et al., C.A. No. 3:13-00126 ... Robert Loftus, et al. v.

Court - US Case Law


Apr 15, 2016 ... Plaintiff-Appellant, v. AMYLIN PHARMACEUTICALS, INC., et al., ... oped for Amylin's use in marketing its diabetes drug Byetta? The parties' ...

here - Delaware Litigation Blog


May 12, 2009 ... 15 Amylin Pharmaceuticals, Inc., Definitive Proxy Statement of Eastbourne Capital Management,. L.L.C. et al. (Form DEFC14A), at 1-4 (May 4, ...

San Antonio Fire & Police Pension Fund v. Amylin Pharms.,Inc., et ...


May 12, 2009 ... Amylin Pharms.,Inc., et. al., C.A. No. ... agreement (“Credit Agreement”) entered into by, defendant Amylin Pharmaceuticals, Inc. (“Amylin”).

Icahn Partners LP v. Amylin Pharmaceuticals, Inc. - Delaware Courts


Apr 18, 2012 ... Icahn Partners LP v. Amylin Pharmaceuticals, Inc. C.A. No. 7404-VCN. April 20, 2012. Page 2 members of amylinГs board of directors (the ...

motion to withdraw (PDF) - AboutLawsuits.com


Feb 18, 2014 ... Amylin Pharmaceuticals, LLC f/k/a Amylin Pharmaceuticals, Inc., Eli Lilly and Company, and ... 3:13-cv-01114; Elizabeth Childress v. Amylin ...

Approaches to the Pharmacological Treatment of Obesity - Medscape


Other Pharmaceutical Strategies for the Treatment of Obesity · Expert Commentary · Five Year View. References; Sidebar. My Alerts. You have already selected ...

Diabetic diarrhea | SpringerLink


Sep 20, 2009 ... Abstract. Diabetic patients with diarrhea may present clinical challenges in diagnosis and treatment. Particular diagnoses are more prevalent in ...